376.823. Section 191.905, RSMo, shall not apply to programsestablished by pharmaceutical companies for the purposes of providing apartial rebate of private health insurance co-payments and coinsurance topatients with multiple sclerosis or other chronic, potentially disabling,or life-threatening conditions who have been prescribed disease-managingmedicines for which there are no generic equivalents.
(L. 2005 H.B. 56)